Progknowse is working to develop and operationalize predictive algorithms for precise, actionable therapeutic recommendations to improve and personalize care delivery, leveraging the PremierConnect platform.
Read More
Renaissance Computing Institute (RENCI) may be the most successful organization in North Carolina that few people have ever heard of. But that’s about to change.
Read MoreBurlington-based global life science company LabCorp and AstraZeneca subsidiary Definiens have announced a collaboration to speed the development of precision medicines.
Read More
A $45,000 NCBiotech Presidential Grant supported two recently completed genetic testing pilot studies at Western North Carolinas MIssion Health System.
Read More
Sound waves may become the next effective tool to help doctors diagnose cancer and develop more personalized diagnostics and treatments.
Read MoreJuly 5 is the last day for the early bird price if you want to attend the Precision Medicine Conference at Duke in September.
Read More
John Ryals, the long-time chief executive officer of life science firm Metabolon and one of the best known biotech executives in the Triangle, has retired.
Read More
AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.
Read More
RTI International is branching out its efforts to fulfill the nonprofit’s global mission of improving the human condition by investing in an emerging genomics and precision medicine startup.
Read More
